Italian medical research foundation specializing in cardiovascular simulation, digital twins, health data interoperability, and cardiac biomaterials.
FTGM is a Pisa-based medical research foundation specializing in cardiovascular disease — from coronary artery simulation and aneurysm modeling to cardiac repair using artificial muscle tissue. They bring strong computational medicine capabilities, combining multi-physics simulation, patient-specific modeling, and high-performance computing to support clinical decision-making. They also contribute to European health data interoperability standards and radiation protection strategies for medical applications.
SMARTool modeled coronary artery disease for clinical decision support; MeDiTATe built medical digital twins for aneurysm treatment; KardiaTool developed point-of-care heart failure diagnostics.
InteropEHRate (their largest funded project at EUR 615k) worked on edge-based interoperable EHRs using HL7 FHIR, peer-to-peer protocols, and citizen empowerment.
REPAIR explores polymeric artificial muscular tissue and smart materials for restoring cardiac mechanical function — an implantable device line running through 2025.
EURAMED rocc-n-roll developed a strategic research agenda for radiation protection across radiotherapy, nuclear medicine, and radiology.
EPoS investigated pathways of steatohepatitis (fatty liver disease), reflecting FTGM's broader clinical research scope beyond cardiology.
FTGM's early H2020 work (2015–2017) centered on classical clinical research — liver disease pathology (EPoS) and coronary artery simulation (SMARTool). From 2019 onward, the foundation shifted decisively toward computational and digital medicine: patient-specific digital twins for aneurysms (MeDiTATe), interoperable health records at the network edge (InteropEHRate), and implantable smart materials (REPAIR). The trajectory shows a clear move from diagnosis-focused clinical studies to digitally-enabled, patient-centered treatment tools.
FTGM is moving toward computational cardiology and digital health infrastructure — expect future work combining patient-specific simulation with interoperable health data systems.
FTGM has never coordinated an H2020 project — they consistently join as a participant or third-party expert, contributing specialized medical and computational know-how to larger consortia. With 97 unique partners across 23 countries, they operate as a well-connected specialist rather than a project leader. This makes them a reliable technical contributor who integrates smoothly into established consortia without demanding a steering role.
FTGM has collaborated with 97 distinct partners across 23 countries, indicating a broad European network built through mid-to-large consortia. Their connections span clinical research centers, universities, and technology developers across Western and Southern Europe.
FTGM sits at the intersection of clinical cardiology and computational engineering — a combination few medical foundations can match. Their ability to contribute both real patient data and multi-physics simulation expertise (CFD, FEM, HPC, GPU computing) makes them a valuable bridge between clinical needs and digital solutions. For consortium builders, they offer a credible clinical validation partner who understands both the medicine and the math.
